Artificial Intelligence (AI) is now a major force in the U.S. economy. The rapid expansion of data centers in the United States has emphasized the challenges facing the U.S. electricity sector, which ...

Massive data centers are pushing energy demand higher. Some people claim that AI will be a net benefit for the grid. The rising popularity of AI is driving an increase in electricity demand so ...

PEMBROKE PINES, FLORIDA - MAY 16: High voltage power lines run along the electrical power grid on May 16, 2024, in Pembroke Pines, Florida. The grid is strained by increasing demand from ...

Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases, eliminating the need for preconditioning chemotherapy. Lead candidate Descartes-08 showed promising ...

U.S. power infrastructure—the intricate physical fabric that laces together generation, transmission, and distribution—is under intensifying strain. Outdated and overextended, it must now absorb ...

FREDERICK, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, ...

This story originally appeared on Vox and is part of the Climate Desk collaboration. The tricky thing about generating electricity is that for the most part, you pretty much have to use it or lose it.

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...

Section 1. Purpose. The United States is experiencing an unprecedented surge in electricity demand driven by rapid technological advancements, including the expansion of artificial intelligence data ...

For Java-based programs such as Maven, Jenkins, Gradle or Tomcat to run, they need to know that Java's JDK is installed. That's the purpose of the JAVA_HOME environment variable. It tells programs ...

Phase 3 trial of Descartes-08 in myasthenia gravis to start in 1H25 Cartesian Therapeutics has secured an agreement from the US Food and Drug Administration (FDA) under the Special Protocol Assessment ...